Tumor infiltrating lymphocytes and change in tumor load on MRI to assess response and prognosis after neoadjuvant chemotherapy in breast cancer
The combination of TILs and MRI is informative of response to NAC in patients with both ER+/HER2- and TN&HER2+ tumors.
Authors
- Roberto Salgado (ORCID: https://orcid.org/0000-0002-1110-3801)
- Bas B. L. Penning de Vries (ORCID: https://orcid.org/0000-0001-9989-7732)
- Kenneth G. A. Gilhuijs (ORCID: https://orcid.org/0000-0003-2087-8649)
- Markus H. A. Janse (ORCID: https://orcid.org/0000-0002-0604-1204)
- L. Janssen (ORCID: https://orcid.org/0000-0003-1157-8978)
- Sjoerd G. Elias (ORCID: https://orcid.org/0000-0003-3903-4024)
- Elsken van der Wall (ORCID: https://orcid.org/0000-0003-2568-6937)
- P. J. van Diest
Institutions
- Utrecht University (NL)
- Peter MacCallum Cancer Centre (AU)
- University Medical Center Utrecht (NL)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1007/s10549-024-07484-7
- Citations
- 2
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- European Commission
- Horizon 2020